Operating Segments (Tables)

3 Months Ended

Mar. 31, 2013

Reportable Segments Summarized Financial Information

Summarized financial information concerning our reportable segments is shown in the following table. Corporate & other includes corporate-related items not allocated to the reportable segments.

	Three Months Ended March 31,
	2013			2012
	(In thousands)
Net sales:
Polymer Solutions	$	214,774		$	228,131
Catalysts		235,573			293,522
Fine Chemistry		191,278			190,051
Total net sales	$	641,625		$	711,704
Segment operating profit:
Polymer Solutions	$	43,670		$	54,547
Catalysts		49,045			76,641
Fine Chemistry		36,178			44,363
Total segment operating profit		128,893			175,551
Equity in net income of unconsolidated investments:
Polymer Solutions		2,308			1,845
Catalysts		7,953			6,741
Fine Chemistry		—			—
Corporate & other		—			—
Total equity in net income of unconsolidated investments		10,261			8,586
Net (income) loss attributable to noncontrolling interests:
Polymer Solutions		(708	)		(1,002	)
Catalysts		—			—
Fine Chemistry		(4,821	)		(3,372	)
Corporate & other		—			3
Total net income attributable to noncontrolling interests		(5,529	)		(4,371	)
Segment income:
Polymer Solutions		45,270			55,390
Catalysts		56,998			83,382
Fine Chemistry		31,357			40,991
Total segment income		133,625			179,763
Corporate & other		(14,006	)		(17,621	)
Interest and financing expenses		(5,231	)		(8,734	)
Other expenses, net		(4,209	)		(118	)
Income tax expense		(26,192	)		(39,028	)
Net income attributable to Albemarle Corporation	$	83,987		$	114,262